We aim to transform global cancer treatment – aligned with the current direction of global healthcare strategy which is focussed on preventative medicine and earlier diagnosis – offering initially an innovative alternative to conventional breast cancer surgery – through US, UK & EU patented, minimally invasive, microwave technology – that enables safer, faster, and a more sustainable alternative – targeting tumours precisely with a novel pulsed microwave therapy – at low power levels, thereby generating less heat (previously a critical limiting factor) – advancing patient care by reducing side-effects and anaesthetic risks - reshaping the future of oncology globally enabling precise, rapid outpatient therapy – benefitting patients while materially reducing healthcare providers’ costs.

NovoRadiant Limited

Org chart

Teams

Offices